Treatment of Chronic HCV in End-Stage Renal Disease Advances in 2016: Internet Enduring Material

Treatment of Chronic HCV in End-Stage Renal Disease Advances in 2016: Internet Enduring Material

The focus of this CME Internet Activity is to increase your Ability to Screen, Diagnose and Treat your Hemodialysis Patient for Hepatitis C.

 

Those who complete this activity will better understand how to screen, diagnose and treat the appropriate candidates with HCV under their care and when and how to refer to Hepatology for more advanced care.

Target Audience

The target audience for this activity is Nephrologists, Gastroenterologists and Internists as well as related mid-level providers and nurse specialists.  

Joint Provider Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Louisville and SC Liver Research Consortia. The University of Louisville is accredited by the ACCME to provide continuing education for physicians.

Designation Statement
The University of Louisville Office of Continuing Medical Education & Professional Development designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions 
This online CME activity has been developed by the University of Louisville School of Medicine in joint providership with SC Liver Research Consortia. During the course you will watch and listen to a video presentation. You will have to register and create a user profile before you are able to view the video and post-test material. Once the material has been reviewed, you will take a brief post-activity quiz followed by course evaluations, after which you will be able to generate your CME/CE certificate.

Hardware & Software Requirements
High speed internet connection
Browser: Google Chrome is recommended

Course Director
Paul Pockros, MD  
 
Director, Liver Disease Center
Scripps Clinic
La Jolla, CA

Course Coordinator
Howard J, Horwitz, MPH    

CME Director
SC Liver Research Consortia
Del Mar, CA

Planning Committee Members
Matthew Cave, MD    
Associate Professor of Medicine
University of Louisville School of Medicine
Louisville, KY

Cathleen Frenette, MD    
Clinical Director, Liver Transplantation
Scripps Health
La Jolla, CA

Howard J, Horwitz, MPH    
CME Director
SC Liver Research Consortia
Del Mar, CA

Paul Pockros, MD    
Director, Liver Disease Center
Scripps Health
La Jolla, CA

Participating Faculty
Paul Pockros, MD    
Director, Liver Disease Center
Scripps Health
La Jolla, CA

Disclosures
As a provider accredited by the ACCME, the Office of CME&PD, School of Medicine, University of Louisville, must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All Planners, faculty, reviewers, and other persons that affected the content of this CME activity were required to submit a financial disclosure form from which relevant conflicts of interest were determined.

Course Director and Coordinator
Paul J. Pockros, MD and Howard J. Horwitz, MPH have no relevant financial relationships with any commercial interests to disclose.

Planning Committee Members
The planning committee members listed above have no relevant financial relationships with any commercial interests to disclose.

Participating Faculty
The participating faculty member listed above have no relevant financial relationships with any commercial interests to disclose.

The CME & PD staff and Advisory Board have no relevant financial relationships with any commercial interests to disclose.

Original Release & Termination Dates
Medium or combination of media used: Online enduring material activity
Method of Physician Participation: Online video presentation
Estimated time to complete the educational activity: 1.0 hours
Course Originally Released On: 12/13/2016
Date of Most Recent Review: 12/13/2016
Course Termination Date: 12/13/2017

Special Services
If you need special accommodations due to a disability, or for an alternative form of course materials, please contact Howard Horwitz. Continuing Medical Education & Professional Development fully complies with the legal requirements of the ADA and the rules and regulations thereof.

Provider Contact Information
If you need technical support or have questions about the course, please e-mail us at cmepd@louisville.edu

Privacy Policy
The University of Louisville's Continuing Medical Education and Professional Development office respects your privacy. Personal information collected from participants of our medical educational activities will not, unless required by law, be shared with any third party. The primary reason we collect your personal information is for accountability and documentation of your continuing education activities in compliance with Accreditation Council for Continuing Medical Education (ACCME) regulations. We do not distribute unsolicited e-mails, nor, unless required by law, do we share the names of our subscribers with any third party.

Copyright
The University of Louisville has obtained permission to use the content in this educational activity.

Commercial Support
This Internet Activity Enduring Material is Supported by an educational grant from Merck.

Course Learning Objectives
1. Recognize the epidemiology of Hepatitis C (HCV) in kidney disease patients, especially those undergoing hemodialysis (HD).
2. Explain the various risk factors for HCV infection among HD patients.
3. Identify HCV and Risk of Death in Long-Term Hemodialysis Patients.
4. Identify how HCV can be a cause of Renal Disease and other Immune Complex Disorders.
5. Investigate the impact of HCV on kidney transplant patients.
6. Implement the current diagnostic approaches for HCV and the efficacy of each.
7. Utilize the benefits and limitations of liver biopsy and fibrosis testing in workup of kidney patients.
8. Translate the widely held medical pearls in the evaluation of HCV infection in kidney disease.
9. Examine the latest research findings on the treatment of HCV to provide therapeutic options of patients with kidney disease.
10. Discuss therapeutic and patient management options though a series of clinical case presentations.
11. Describe how to screen, diagnose and effectively treat the appropriate kidney patients and identify when and how to refer to a Hepatologist for more advanced liver care.

Treatment of Chronic HCV in End-Stage Renal Disease Advances in 2016 Online Module

  • Once you have finished viewing the material you can either close the presentation window or select the CME Tracker Thank You window at the top of the screen to continue with your post-test, evaluation, and generation of your CME certificate.
  • If you are not able to complete a module in one sitting you will be able to re-access the material once you have registered for the course. Click on the module links below and sign in at the Activity Registration page and you will again have access to the course material.

Registration Fees

All Participants $15 to participate in this activity:

TO CREATE YOUR USER PROFILE AND BEGIN THE COURSE   CLICK HERE